One-Step Semisynthesis of Oleacein and the Determination as a 5‑Lipoxygenase Inhibitor

The dialdehydes oleacein (<b>2</b>) and oleocanthal (<b>4</b>) are closely related to oleuropein (<b>1</b>) and ligstroside (<b>3</b>), the two latter compounds being abundant iridoids of <i>Olea europaea</i>. By exploiting oleuropein isolated from the plant leaf extract, an efficient procedure has been developed for a one-step semisynthesis of oleacein under Krapcho decarbomethoxylation conditions. Highlighted is the fact that 5-lipoxygenase is a direct target for oleacein with an inhibitory potential (IC₅₀: 2 μM) more potent than oleocanthal (<b>4</b>) and oleuropein (<b>1</b>). This enzyme catalyzes the initial steps in the biosynthesis of pro-inflammatory leukotrienes. Taken together, the methodology presented here offers an alternative solution to isolation or total synthesis for the procurement of oleacein, thus facilitating the further development as a potential anti-inflammatory agent

Indirubin Core Structure of Glycogen Synthase Kinase‑3 Inhibitors as Novel Chemotype for Intervention with 5‑Lipoxygenase

The enzymes 5-lipoxygenase (5-LO) and glycogen synthase kinase (GSK)-3 represent promising drug targets in inflammation. We made use of the bisindole core of indirubin, present in GSK-3 inhibitors, to innovatively target 5-LO at the ATP-binding site for the design of dual 5-LO/GSK-3 inhibitors. Evaluation of substituted indirubin derivatives led to the identification of (3<i>Z</i>)-6-bromo-3-[(3<i>E</i>)-3-hydroxyiminoindolin-2-ylidene]­indolin-2-one (<b>15</b>) as a potent, direct, and reversible 5-LO inhibitor (IC₅₀ = 1.5 μM), with comparable cellular effectiveness on 5-LO and GSK-3. Together, we present indirubins as novel chemotypes for the development of 5-LO inhibitors, the interference with the ATP-binding site as a novel strategy for 5-LO targeting, and dual 5-LO/GSK-3 inhibition as an unconventional and promising concept for anti-inflammatory intervention